InvestorsObserver
×
News Home

Should You Sell Edesa Biotech Inc (EDSA) in Biotechnology Industry?

Wednesday, November 22, 2023 10:08 AM | InvestorsObserver Analysts

Mentioned in this article

Should You Sell Edesa Biotech Inc (EDSA) in Biotechnology Industry?

A rating of 77 puts Edesa Biotech Inc (EDSA) near the top of the Biotechnology industry according to InvestorsObserver. Edesa Biotech Inc's score of 77 means it scores higher than 77% of stocks in the industry. Edesa Biotech Inc also received an overall rating of 60, putting it above 60% of all stocks. Biotechnology is ranked 53 out of the 148 industries.

Overall Score - 60
EDSA has an Overall Score of 60. Find out what this means to you and get the rest of the rankings on EDSA!

What do These Ratings Mean?

Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 60 means the stock is more attractive than 60 percent of stocks.
These rankings allows you to easily compare stocks and view what the strengths and weaknesses are of a given company. This lets you find the stocks with the best short and long term growth prospects in a matter of seconds. The combined score incorporates technical and fundamental analysis in order to give a comprehensive overview of a stocks performance. Investors who then want to focus on analysts rankings or valuations are able to see the separate scores for each section.

What's Happening With Edesa Biotech Inc Stock Today?

Edesa Biotech Inc (EDSA) stock is trading at $3.24 as of 9:57 AM on Wednesday, Nov 22, an increase of $0.44, or 15.71% from the previous closing price of $2.80. The stock has traded between $3.11 and $3.24 so far today. Volume today is light. So far 13,236 shares have traded compared to average volume of 156,701 shares. Click Here to get the full Stock Report for Edesa Biotech Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App